AN2 Therapeutics, Inc. (ANTX) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Menlo Park, CA, 美国. 现任CEO为 Eric E. Easom.
ANTX 拥有 IPO日期为 2022-03-25, 22 名全职员工, 在 NASDAQ Global Select, 市值为 $89.33M.
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
